Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Gufic Biosciences to launch Botulinum Neuromedicine in India

      Gufic Biosciences to launch Botulinum Neuromedicine in India

      Medical Dialogues Bureau20 July 2019 9:15 AM IST
      Mumbai: Gufic Biosciences Limited ("the Company") recently announced to launch Botulinum Neurotoxin in India in collaboration with USA based Company...
      Bayer welcomes call for new trial in $2 billion glyphosate-based weedkiller case

      Bayer welcomes call for new trial in $2 billion glyphosate-based weedkiller case

      Medical Dialogues Bureau20 July 2019 9:00 AM IST
      Bayer had asked Judge Smith in June to overrule the jury verdict that its Roundup weedkiller caused the couple's non-Hodgkin's Lymphoma (NHL), arguing...
      HC pulls up Pharma co for violating court orders, directs it to plant 33,000 more saplings

      HC pulls up Pharma co for violating court orders, directs it to plant 33,000 more saplings

      Medical Dialogues Bureau19 July 2019 4:55 PM IST
      New Delhi: The Delhi High Court Wednesday termed as "a racket" the submission of a private company, directed to plant 1.4 lakh saplings worth Rs 80...
      Cabinet Nod to Rs 330 crore loan to 3 pharma PSUs for clearing staff liabilities

      Cabinet Nod to Rs 330 crore loan to 3 pharma PSUs for clearing staff liabilities

      Medical Dialogues Bureau19 July 2019 3:03 PM IST
      NEW DELHI: The Union Cabinet Wednesday approved loans of Rs 330.35 crore to three state-owned pharma companies to help them clear employees'...
      Abbott hits record high as blood sugar monitoring device- FreeStyle Libre 2 fuels profit

      Abbott hits record high as blood sugar monitoring device- FreeStyle Libre 2 fuels profit

      Medical Dialogues Bureau19 July 2019 3:02 PM IST
      Abbott Laboratories beat analysts' estimates for quarterly profit and lifted its full-year earnings forecast on Wednesday, boosted by a near 64% jump...
      Novartis key multiple sclerosis drug Gilenya® approved by China NMPA

      Novartis key multiple sclerosis drug Gilenya® approved by China NMPA

      Medical Dialogues Bureau19 July 2019 2:50 PM IST
      Basel: Chinese National Medical Products Administration (NMPA) approved Novartis's drug Gilenya® for relapsing forms of multiple sclerosis (RMS) for...
      USFDA completes inspection at Laurus Labs

      USFDA completes inspection at Laurus Labs' AP unit

      Medical Dialogues Bureau19 July 2019 10:02 AM IST
      Mumbai: Laurus labs recently announced that they have completed the US Food and Drug Administration (USFDA) inspection of Unit 4 at Visakhapatnam,...
      Sterling Biotech bank fraud case: ED records statements of actor Dino Morea, DJ Aqeel

      Sterling Biotech bank fraud case: ED records statements of actor Dino Morea, DJ Aqeel

      Medical Dialogues Bureau19 July 2019 9:02 AM IST
      New Delhi: The Enforcement Directorate has recorded the state ments of Bollywood actor Dino Morea and DJ Aqeel in connection with the Sterling Biotech...
      Wockhardt new antibiotics under development to have positive impact in future, says founder Khorakiwala

      Wockhardt new antibiotics under development to have positive impact in future, says founder Khorakiwala

      Medical Dialogues Bureau18 July 2019 3:13 PM IST
      In his address to shareholders in the Annual Report for 2018-19, Khorakiwala said Wockhardt has several new chemical entities (NCEs) which are being...
      Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila

      Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila

      Medical Dialogues Bureau18 July 2019 9:17 AM IST
      "Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
      Abbott wins USFDA approval for blood plasma screening system Alinity s

      Abbott wins USFDA approval for blood plasma screening system Alinity s

      Medical Dialogues Bureau18 July 2019 9:15 AM IST
      Abbott's Alinity s is designed to screen blood and plasma more efficiently within a smaller space versus commercially available competitive...
      Federal data shows opioid shipments ballooned by over 50pc as crisis grew

      Federal data shows opioid shipments ballooned by over 50pc as crisis grew

      Medical Dialogues Bureau18 July 2019 9:00 AM IST
      While OxyContin is the best-known prescription opioid, the Post analysis shows that Purdue accounted for just 3% of pills sold during that time. Three...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok